Modified CLL International Prognostic Index (CLL-LIPI) using lymphocyte doubling time (LDT) in place of IgHV mutation status in resource-limited settings predicts time to first treatment and overall survival

Leuk Lymphoma. 2020 Jun;61(6):1512-1515. doi: 10.1080/10428194.2020.1719099. Epub 2020 Jan 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Immunoglobulin Variable Region / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell* / diagnosis
  • Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell* / therapy
  • Lymphocytes
  • Mutation
  • Prognosis

Substances

  • Immunoglobulin Variable Region